72788-88-6 Usage
General Description
(5-Methoxypyrazin-2-yl)Methanol, also known as 2-Hydroxy-5-methoxypyrazine, is a chemical compound with the molecular formula C6H8N2O2. It is commonly found in certain foods and beverages, including fruits, vegetables, and wine. (5-Methoxypyrazin-2-yl)Methanol is responsible for the earthy, smoky, and green bell pepper-like aromas found in these products. It is often used in the food and beverage industry as a flavoring agent to enhance the sensory attributes of various products. Additionally, (5-Methoxypyrazin-2-yl)Methanol has been studied for its potential use in the pharmaceutical industry for its antimicrobial and antioxidant properties. Overall, this chemical compound plays a significant role in both the flavoring and potential health benefits of various products.
Check Digit Verification of cas no
The CAS Registry Mumber 72788-88-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,2,7,8 and 8 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 72788-88:
(7*7)+(6*2)+(5*7)+(4*8)+(3*8)+(2*8)+(1*8)=176
176 % 10 = 6
So 72788-88-6 is a valid CAS Registry Number.
72788-88-6Relevant articles and documents
PYRAZOLOPYRIDINE COMPOUND AS RET INHIBITOR AND APPLICATION THEREOF
-
, (2022/02/19)
Disclosed is a series of pyrazolopyridine compounds, and application thereof in the preparation of RET kinase inhibitors for treatment. Specifically disclosed is the compound represented by formula (I), or a pharmaceutically acceptable salt thereof.
1H-PYRAZOLO[4,3-B]PYRIDINES AS PDE1 INHIBITORS
-
, (2019/07/10)
The present invention provides 1H-pyrazolo[4,3-b]pyridines of formula (I) as PDE1 inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders.
COMBINATION TREATMENTS COMPRISING ADMINISTRATION OF 1H-PYRAZOLO[4,3-B]PYRIDINES
-
, (2019/07/19)
The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors together with a second compound which compound is useful in the treatment of a psychiatric disorder and their combined use as a medicament, in particular for the treatment of psychiatric and/or cognitive disorders.
